3 Individual nutritional and inflammatory markers for predicting postoperative complications In clinical practice, utilizing single, easily accessible biomarkers for risk assessment is the most cost-effective and feasible approach
Daily tracking provides objective data
In our study, methimazole-nave patients had an elevated serum level of palmitic acid and this was decreased after methimazole treatment
(2) developing combination therapies for specific pathological subtypes, including potential synergistic benefits with mitochondria-targeted antioxidants (e.g., MitoQ) or bile acid modulators (e.g., ursodeoxycholic acid, UDCA) in MASH patients with prominent ballooning degeneration or cholestatic features
Serum free copper in Wilson disease
PPARGC1A and ADIPOQ polymorphisms are associated with aggressive prostate cancer in Mexican-Mestizo men with overweight or obesity